Related references
Note: Only part of the references are listed.The brain acid-soluble protein 1 (BASP1) interferes with the oncogenic capacity of MYC and its binding to calmodulin
Markus Hartl et al.
MOLECULAR ONCOLOGY (2020)
Roles and mechanisms of alternative splicing in cancer - implications for care
Sophie C. Bonnal et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
The role of WT1 in breast cancer: clinical implications, biological effects and molecular mechanism
Ye Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue
Qimin Zhou et al.
EBIOMEDICINE (2019)
Co-activation of WT1 and AP-1 proteins on WT1 gene promoter to induce WT1 gene expression in K562 cells
Songyot Anuchapreeda et al.
CELLULAR SIGNALLING (2019)
Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1
Kay-Dietrich Wagner et al.
CELLS (2019)
The WT1-BASP1 complex is required to maintain the differentiated state of taste receptor cells
Yankun Gao et al.
LIFE SCIENCE ALLIANCE (2019)
DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and -KTS isoformsFrom initial observations to recent global genomic analyses
Tove Ullmark et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2018)
SRPK1 is a poor prognostic indicator and a novel potential therapeutic target for human colorectal cancer
Nan Yi et al.
ONCOTARGETS AND THERAPY (2018)
Methylation-associated silencing of BASP1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia
Lei Zhou et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Transcription factor Wilms' tumor 1 regulates developmental RNAs through 3′ UTR interaction
Ruthrothaselvi Bharathavikru et al.
GENES & DEVELOPMENT (2017)
WT1 Alternative Splicing: Role of Its Isoforms in Neuroblastoma
Daniela Maria Rasa et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2017)
Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease
Jennifer Batson et al.
ACS CHEMICAL BIOLOGY (2017)
Serine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasion
Nicholas Bullock et al.
JOURNAL OF CLINICAL PATHOLOGY (2016)
Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant
Wies van Roosmalen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer
A. Mavrou et al.
ONCOGENE (2015)
Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1)
Eneda Toska et al.
BIOCHEMICAL JOURNAL (2014)
Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma
M. V. Gammons et al.
BRITISH JOURNAL OF CANCER (2014)
Hallmarks of alternative splicing in cancer
S. Oltean et al.
ONCOGENE (2014)
Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events
Jung-Chun Lin et al.
RNA (2014)
The Wilms' tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression
Kay-Dietrich Wagner et al.
NATURE COMMUNICATIONS (2014)
The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells
Adina Brett et al.
MOLECULAR CANCER (2013)
The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation
Olga Anczukow et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Repression of Transcription by WT1-BASP1 Requires the Myristoylation of BASP1 and the PIP2-Dependent Recruitment of Histone Deacetylase
Eneda Toska et al.
CELL REPORTS (2012)
WT1 and its transcriptional cofactor BASP1 redirect the differentiation pathway of an established blood cell line
Sarah J. Goodfellow et al.
BIOCHEMICAL JOURNAL (2011)
WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing
Elianna M. Amin et al.
CANCER CELL (2011)
A Wt1-Controlled Chromatin Switching Mechanism Underpins Tissue-Specific Wnt4 Activation and Repression
Abdelkader Essafi et al.
DEVELOPMENTAL CELL (2011)
Inhibition of Hepatitis C Virus Replication by a Specific Inhibitor of Serine-Arginine-Rich Protein Kinase
Yuko Karakama et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic Isoforms A NOVEL THERAPEUTIC STRATEGY FOR ANGIOGENESIS
Dawid G. Nowak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
WT1 the Oncogene: A Tale of Death and HtrA
Abdelkader Essafi et al.
MOLECULAR CELL (2010)
Molecular Diversity of VEGF-A as a Regulator of Its Biological Activity
Jeanette Woolard et al.
MICROCIRCULATION (2009)
Dynamic interaction between WT1 and BASP1 in transcriptional regulation during differentiation
Laura M. Green et al.
NUCLEIC ACIDS RESEARCH (2009)
Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors
Dawid G. Nowak et al.
JOURNAL OF CELL SCIENCE (2008)
Alternative isoform regulation in human tissue transcriptomes
Eric T. Wang et al.
NATURE (2008)
Alternative splicing in angiogenesis: The vascular endothelial growth factor paradigm
Michael R. Ladomery et al.
CANCER LETTERS (2007)
The gene encoding the splicing factor SF2/ASF is a proto-oncogene
Rotem Karni et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Presence of WT1 in nuclear messenger RNP particles in the human acute myeloid leukemia cell lines HL60 and K562
Avril A. Morrison et al.
CANCER LETTERS (2006)
Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiation
JA Davies et al.
HUMAN MOLECULAR GENETICS (2004)
Transcriptional activation of c-myc proto-oncogene by WT1 protein
YQ Han et al.
ONCOGENE (2004)
The role of WT1 in oncogenesis: Tumor suppressor or oncogene?
DM Loeb et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2002)
Transcription factors: bound to activate or repress
DS Latchman
TRENDS IN BIOCHEMICAL SCIENCES (2001)
Share Paper
